Showing results (11-20 of 69) with videos related to
Sort By:
Pageof 7
Clinical and Experimental Pharmacology & Physiology|March 19, 2008
Cyp2d6*3, *4, *5 and *6 polymorphisms and antipsychotic-induced extrapyramidal side-effects in patients receiving antipsychotic therapyAnna Crescenti, Sergi Mas, Patricia Gassó, et al.Fundamental & Clinical Pharmacology|January 1, 2010
Lack of association between schizophrenia and polymorphisms in dopamine metabolism and transport genesSanti Alvarez, Sergi Mas, Patricia Gassó, et al.Journal of Psychiatric Research|October 17, 2013
Increased susceptibility to apoptosis in cultured fibroblasts from antipsychotic-naïve first-episode schizophrenia patientsPatricia Gassó, Sergi Mas, Oriol Molina, et al.Molecular Psychiatry|January 31, 2026
Neuroinflammation: an unfortunate term to describe schizophreniaVicent Llorca-Bofí, Eduard Parellada, Constanza Morén, et al.International Clinical Psychopharmacology|August 18, 2017
Real-world data on paliperidone palmitate for the treatment of schizophrenia and other psychotic disorders: a systematic review of randomized and nonrandomized studiesRobin Emsley, Eduard Parellada, Miquel Bioque, et al.Neuropsychobiology|October 4, 2008
Association of A/G polymorphism in intron 13 of the monoamine oxidase B gene with schizophrenia in a Spanish populationPatricia Gassó, Miquel Bernardo, Sergi Mas, et al.International Clinical Psychopharmacology|April 7, 2005
Efficacy and safety of direct transition to risperidone long-acting injectable in patients treated with various antipsychotic therapiesHans-Jürgen Möller, Pierre-Michel Llorca, Emilio Sacchetti, et al.Psychopharmacology|November 19, 2003
Striatal dopamine D2 receptor density in neuroleptic-naive and in neuroleptic-free schizophrenic patients: an 123I-IBZM-SPECT studyFrancisco Lomeña, Ana M Catafau, Eduard Parellada, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 11, 2009
ARVCF single marker and haplotypic association with schizophreniaSergi Mas, Miquel Bernardo, Eduard Parellada, et al.European Psychiatry : the Journal of the Association of European Psychiatrists|March 28, 2009
Cannabis use and age of diagnosis of schizophreniaGisela Sugranyes, Itziar Flamarique, Eduard Parellada, et al.Pageof 7